NCT04218682

Brief Summary

This study evaluates the efficacy of an interactive mobile game, Shadow's Edge, on enhancing resilience, promoting identity development, and decreasing somatic symptoms among adolescent and young adult survivors of cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
177

participants targeted

Target at P50-P75 for not_applicable cancer

Timeline
Completed

Started Dec 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 10, 2018

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 2, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 6, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
Last Updated

November 15, 2024

Status Verified

November 1, 2024

Enrollment Period

1.3 years

First QC Date

January 2, 2020

Last Update Submit

November 13, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Resilience

    Resilience will be measured by participant responses to the Brief Resilience Scale (BRS), a 6-item measure with response options on 5-point Likert scale ranging from "1, strongly disagree" to "5, strongly agree" and total scores ranging from 6 to 30 (higher scores indicating greater resilience).

    Baseline to 14-week follow-up

Secondary Outcomes (14)

  • Perceived benefit and burden

    Baseline to 14-week follow-up

  • Life meaning and purpose

    Baseline to 14-week follow-up

  • Fatigue

    Baseline to 14-week follow-up

  • Pain Intensity

    Baseline to 14-week follow-up

  • Positive affect

    Baseline to 14-week follow-up

  • +9 more secondary outcomes

Other Outcomes (1)

  • Intervention satisfaction

    14-weeks post-enrollment

Study Arms (2)

Immediate Game Use

EXPERIMENTAL

AYACS randomly assigned to this arm will immediately play the Shadow's Edge Game following enrollment for a duration of 7 weeks. Following the designated 7-week game-play period, they will continue to have access to the game. They will continue to receive all usual care health care throughout and following the study.

Behavioral: Shadow's Edge Mobile Application Gameplay

Wait-List Comparison Group

NO INTERVENTION

AYACS randomly assigned to this arm will begin to play the Shadow's Edge game 7 weeks following enrollment. They will continue to receive all usual health care throughout and following the study.

Interventions

6 weeks of individual, interactive game play of the Shadow's Edge mobile app.

Immediate Game Use

Eligibility Criteria

Age13 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Adolescent/young adults 13-24 years of age
  • Adolescent/young adult English-speaking at a second grade level
  • Parent/guardian English- or Spanish-speaking at a second grade level (for participants younger than 18 years of age)
  • Patients with history of hematological malignancies (e.g., acute lymphoblastic leukemia) at maintenance phase of treatment or beyond or solid tumor patients (e.g., osteosarcoma) who have completed active treatment or cancer survivors with any form of malignancy history (excluding brain tumors) and are at least 2 years post-diagnosis of the malignancy
  • Consistent access to a mobile phone and/or internet service

You may not qualify if:

  • Brain tumor history
  • History of moderate to severe neurodevelopmental disorder (e.g., autism spectrum disorder)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, 60611, United States

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Bonnie Essner, PhD

    Ann & Robert H Lurie Children's Hospital of Chicago

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: This is a waitlist randomized controlled study in which participants are randomly assigned to immediately begin to play the game (intervention) following enrollment versus wait 6 weeks to play the game following study enrollment. Participants will continue to receive all clinical care as usual throughout and following the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatric Psychologist

Study Record Dates

First Submitted

January 2, 2020

First Posted

January 6, 2020

Study Start

December 10, 2018

Primary Completion

April 1, 2020

Study Completion

April 1, 2020

Last Updated

November 15, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations